News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

What’s #GivingTuesday All About?

By MDA Staff | November 12, 2019
MDA logo
Blog Post

Solid Biosciences Releases Letter to DMD Community Announcing Hold on IGNITE DMD Trial Due to a Serious Adverse Event

By MDA Staff | November 12, 2019
Blog Post

Roche Genentech Releases Letter to DMD Community Announcing Discontinuation of Clinical Trials Program for DMD

By MDA Staff | November 6, 2019
Blog Post

MDA Care Centers Combine Expert Care with Research, Clinical Trials, and Advanced Technology

By Jeanene Swanson | November 5, 2019
MDA logo
Blog Post

AveXis Releases Letter to SMA Community: FDA Places Partial Hold on Clinical Trials for Intrathecally Delivered AVXS-101

By MDA Staff | November 1, 2019
Blog Post

World Muscle Society Roundup: Clinical Trial Results of Treatments in Development for DMD, XLMTM, SMA, and Pompe Disease

By Jeanene Swanson | October 31, 2019
Blog Post

Reata Pharmaceuticals Announces Positive Results from Pivotal Study of Omaveloxolone in FA

By Jeanene Swanson | October 30, 2019
Blog Post

Capricor Therapeutics Announces Positive Interim Results from Phase 2 Study of CAP-1002 to Treat DMD

By Jeanene Swanson | October 29, 2019
Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019